Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men
Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Huma...
Saved in:
Published in | BMC infectious diseases Vol. 14; no. 1; p. 671 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
16.12.2014
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population.
In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16.
We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59.
HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. |
---|---|
AbstractList | Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. Background Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. Methods In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. Results We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. Conclusions HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. Keywords: HIV, HPV, MSM, Type 16, Variants, Anal cancer Doc number: 671 Abstract Background: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. Methods: In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. Results: We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. Conclusions: HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. BACKGROUND: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. METHODS: In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. RESULTS: We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. CONCLUSIONS: HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. BACKGROUNDAnal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population.METHODSIn the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16.RESULTSWe found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59.CONCLUSIONSHIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. |
ArticleNumber | 671 |
Audience | Academic |
Author | García-Carrancá, Alejandro Caro-Vega, Yanink de León, David Cantú Crabtree-Ramírez, Brenda Méndez-Martínez, Rocío Rivera-Martínez, Norma E Galván, Silvia C Sierra-Madero, Juan G |
Author_xml | – sequence: 1 givenname: Rocío surname: Méndez-Martínez fullname: Méndez-Martínez, Rocío email: rocmenmar@yahoo.com organization: División de Investigación, Instituto Nacional de Cancerología, Secretaría de Salud (SSA), México D.F., Mexico. rocmenmar@yahoo.com – sequence: 2 givenname: Norma E surname: Rivera-Martínez fullname: Rivera-Martínez, Norma E email: normaerm@hotmail.com organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. normaerm@hotmail.com – sequence: 3 givenname: Brenda surname: Crabtree-Ramírez fullname: Crabtree-Ramírez, Brenda email: brendcrabtree@hotmail.com organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. brendcrabtree@hotmail.com – sequence: 4 givenname: Juan G surname: Sierra-Madero fullname: Sierra-Madero, Juan G email: jsmadero@yahoo.com organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. jsmadero@yahoo.com – sequence: 5 givenname: Yanink surname: Caro-Vega fullname: Caro-Vega, Yanink email: yaninkc@yahoo.com.mx organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. yaninkc@yahoo.com.mx – sequence: 6 givenname: Silvia C surname: Galván fullname: Galván, Silvia C email: sgalvan@servidor.unam.mx organization: Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México D.F., Mexico. sgalvan@servidor.unam.mx – sequence: 7 givenname: David Cantú surname: de León fullname: de León, David Cantú email: dcantu3@excite.com organization: Dirección de Investigación Clínica, Instituto Nacional de Cancerología, Secretaría de Salud (SSA), México D.F., Mexico. dcantu3@excite.com – sequence: 8 givenname: Alejandro surname: García-Carrancá fullname: García-Carrancá, Alejandro email: carranca@biomedicas.unam.mx, carranca@biomedicas.unam.mx organization: Laboratory of Virus & Cancer Instituto Nacional de Cancerología, Av. San Fernando No. 22, Colonia Sección XVI, México D.F., Tlalpan, 14080, México. carranca@biomedicas.unam.mx |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25510243$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkttq3DAQhk1JaQ7tA_SmCHrTXjjVwZa8N4WQngIpgZ5uhawdrRVkybHsTfY1-sSVs9s0LikUgyzPfPNbmn8Osz0fPGTZc4KPCan4m0hoJRY5JkWOuSB58Sg7IEXaUMaKvXv7_ewwxkuMiajo4km2T8uSYFqwg-zn59ENtnOAmrFVHnWqs86FVq1tP0ZkvQE92OAjUn1i7KpxG9T1sFYO_JDyaGgAKa8c0rdrMDsl27ajD0swVlvweoNuFfMuRDvYNaAWPLpuAmpU-ohwg67t0EzRp9ljo1yEZ7v3Ufb9w_tvp5_y84uPZ6cn53nNKRtyw4FoXJVEcV0uMSeUAqclLOpSMM6FYWZZiaJWmlUpqik1quYYF4wYqirNjrK3W91urFtY6nSfXjnZ9bZV_UYGZeU8420jV2EtCypSAxdJ4N1WoLbhHwLzjA6t3Homk2dy8kwWSebV7hx9uBohDrK1UYNzykMYoyRcCCbKVJfQl3-hl2HsU9snilWcJ2nxh1olk2SyMKS_60lUnpRsUYqSFtPpjx-g0rOE1uo0aMam-Kzg9awgMQPcDCs1xijPvn75f_bix5wlW1b3IcYezF0HCZbTnD_Ysxf3vbur-D3Y7BdDU_uC |
CitedBy_id | crossref_primary_10_1186_s12992_022_00812_w crossref_primary_10_1186_s13027_021_00385_0 crossref_primary_10_1002_cam4_2720 crossref_primary_10_1093_annonc_mdv606 crossref_primary_10_1371_journal_pone_0235606 crossref_primary_10_1097_MD_0000000000013201 crossref_primary_10_1371_journal_pone_0197845 crossref_primary_10_1159_000518758 crossref_primary_10_18632_oncotarget_20969 crossref_primary_10_1371_journal_pone_0125120 crossref_primary_10_1016_j_jcv_2018_05_010 crossref_primary_10_1111_hiv_12432 crossref_primary_10_1016_j_pvr_2019_01_002 crossref_primary_10_1016_j_jcol_2016_08_003 crossref_primary_10_3748_wjg_v22_i33_7415 crossref_primary_10_5858_arpa_2017_0563_RA crossref_primary_10_1016_j_humpath_2022_06_025 crossref_primary_10_1093_cid_ciac044 crossref_primary_10_1016_S2352_3018_19_30434_5 crossref_primary_10_1186_s12879_019_4677_9 crossref_primary_10_1002_cam4_4458 crossref_primary_10_1002_jmv_24943 crossref_primary_10_1002_jmv_24406 crossref_primary_10_1590_1678_4685_gmb_2017_0331 crossref_primary_10_1007_s00705_017_3697_2 crossref_primary_10_1177_0956462416665288 crossref_primary_10_1002_rmv_2219 crossref_primary_10_1080_21645515_2015_1112474 crossref_primary_10_1093_cid_ciy1012 crossref_primary_10_1097_QAI_0000000000002499 crossref_primary_10_1016_j_heliyon_2024_e32336 crossref_primary_10_1590_0074_02760150405 crossref_primary_10_47892_rgp_2024_441_1601 crossref_primary_10_1016_j_jaad_2015_05_040 crossref_primary_10_1186_s12879_016_1706_9 |
Cites_doi | 10.1093/jnci/djg107 10.1128/JCM.01405-13 10.1093/cid/cir064 10.1067/mjd.2000.105158 10.1093/oxfordjournals.jncimonographs.a003484 10.1371/journal.pone.0015256 10.1001/jama.1990.03440210061033 10.1093/jnci/93.17.1325 10.1093/oxfordjournals.jncimonographs.a003479 10.1081/CNV-100102554 10.1128/jvi.71.3.2463-2472.1997 10.1016/j.soc.2003.12.005 10.1093/oxfordjournals.aje.a116420 10.1056/NEJM200104123441503 10.1016/S1470-2045(12)70080-3 10.1016/j.jcv.2012.02.014 10.1097/00042560-199602010-00009 10.1097/00002030-199810000-00010 10.1097/COH.0b013e32831a7246 10.1097/QCO.0b013e3283229fc8 10.1080/00365590050509913 10.1093/jnci/92.18.1500 10.1086/588145 10.1097/00002030-199511000-00007 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 BioMed Central Ltd. 2014 Méndez Martínez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Méndez Martínez et al.; licensee BioMed Central Ltd. 2014 |
Copyright_xml | – notice: COPYRIGHT 2014 BioMed Central Ltd. – notice: 2014 Méndez Martínez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. – notice: Méndez Martínez et al.; licensee BioMed Central Ltd. 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PIMPY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1186/s12879-014-0671-4 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Science in Context ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Databases Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
EndPage | 671 |
ExternalDocumentID | oai_biomedcentral_com_s12879_014_0671_4 3532591021 A539575249 10_1186_s12879_014_0671_4 25510243 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Mexico |
GeographicLocations_xml | – name: Mexico |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 4.4 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION 7QL 7T2 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PQEST PQUKI 7X8 ABVAZ AFGXO AFNRJ 5PM |
ID | FETCH-LOGICAL-b623t-f6e1c0851a6c5d06122e625e9b573667f3fd874bac385e9c22fab600431f2a8c3 |
IEDL.DBID | RBZ |
ISSN | 1471-2334 |
IngestDate | Tue Sep 17 21:25:03 EDT 2024 Wed May 22 07:13:00 EDT 2024 Fri Oct 25 05:54:24 EDT 2024 Thu Oct 10 17:07:06 EDT 2024 Tue Nov 19 21:30:45 EST 2024 Tue Nov 12 23:35:36 EST 2024 Sat Sep 28 21:06:06 EDT 2024 Sat Sep 28 21:07:05 EDT 2024 Thu Sep 12 18:51:37 EDT 2024 Sat Sep 28 07:56:24 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b623t-f6e1c0851a6c5d06122e625e9b573667f3fd874bac385e9c22fab600431f2a8c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/s12879-014-0671-4 |
PMID | 25510243 |
PQID | 1638668797 |
PQPubID | 42582 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4272559 biomedcentral_primary_oai_biomedcentral_com_s12879_014_0671_4 proquest_miscellaneous_1677375128 proquest_journals_1638668797 gale_infotracmisc_A539575249 gale_infotracacademiconefile_A539575249 gale_incontextgauss_ISR_A539575249 gale_incontextgauss_IOV_A539575249 crossref_primary_10_1186_s12879_014_0671_4 pubmed_primary_25510243 |
PublicationCentury | 2000 |
PublicationDate | 2014-12-16 |
PublicationDateYYYYMMDD | 2014-12-16 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2014 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | 23966501 - J Clin Microbiol. 2013 Nov;51(11):3512-20 2160023 - JAMA. 1990 Jun 6;263(21):2911-6 12807947 - J Natl Cancer Inst Monogr. 2003;(31):57-65 11144896 - Scand J Urol Nephrol Suppl. 2000;(205):189-93 22445259 - Lancet Oncol. 2012 May;13(5):487-500 8869947 - Obstet Gynecol Clin North Am. 1996 Sep;23(3):579-95 9677167 - AIDS. 1998 Jul 9;12(10):1177-84 9032384 - J Virol. 1997 Mar;71(3):2463-72 8561979 - AIDS. 1995 Nov;9(11):1255-62 22418456 - J Clin Virol. 2012 Jun;54(2):185-9 19339939 - Curr Opin HIV AIDS. 2009 Jan;4(1):52-6 21364075 - Clin Infect Dis. 2011 May;52(9):1174-81 10954653 - J Am Acad Dermatol. 2000 Sep;43(3):409-32; quiz 433-6 12807939 - J Natl Cancer Inst Monogr. 2003;(31):3-13 8556400 - J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):178-82 1329500 - Am J Epidemiol. 1992 Jul 1;136(1):54-8 19276878 - Curr Opin Infect Dis. 2009 Apr;22(2):109-14 11338884 - Cancer Invest. 2001;19(3):266-72 18426367 - J Infect Dis. 2008 Jun 15;197(12):1676-84 21151900 - PLoS One. 2010;5(12):e15256 10995805 - J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10 11297703 - N Engl J Med. 2001 Apr 12;344(15):1125-31 14652239 - J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83 11535707 - J Natl Cancer Inst. 2001 Sep 5;93(17):1325-30 15137956 - Surg Oncol Clin N Am. 2004 Apr;13(2):263-75 A Nyitray (671_CR19) 2008; 197 ML Gillison (671_CR8) 2003; 31 M Frisch (671_CR11) 2000; 92 671_CR23 FX Bosch (671_CR1) 2003; 31 D Machalek (671_CR18) 2012; 13 H Pfister (671_CR2) 1996; 23 J Mork (671_CR6) 2001; 344 ML Welton (671_CR3) 2004; 13 J Dillner (671_CR4) 2000; 205 M Torres (671_CR17) 2013; 51 L Gao (671_CR10) 2010; 5 A Czelusta (671_CR20) 2000; 43 CS Rabkin (671_CR21) 1992; 136 A Kreutera (671_CR9) 2009; 22 J Palefsky (671_CR12) 2009; 4 JM Palefsky (671_CR14) 1990; 263 CW Critchlow (671_CR16) 1998; 12 A de Pokomandy (671_CR13) 2014; 52 R Herrero (671_CR7) 2003; 95 RP Villanueva (671_CR22) 2002; 27 DM Aboulafia (671_CR5) 2001; 19 J Berumen (671_CR25) 2001; 93 CW Critchlow (671_CR26) 1995; 9 MG Donà (671_CR24) 2012; 54 RJ Biggar (671_CR15) 1996; 11 |
References_xml | – volume: 95 start-page: 1772 year: 2003 ident: 671_CR7 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djg107 contributor: fullname: R Herrero – volume: 51 start-page: 3512 issue: 11 year: 2013 ident: 671_CR17 publication-title: J Clin Microbiol doi: 10.1128/JCM.01405-13 contributor: fullname: M Torres – volume: 52 start-page: 1174 year: 2014 ident: 671_CR13 publication-title: Clin Infect Dis doi: 10.1093/cid/cir064 contributor: fullname: A de Pokomandy – volume: 43 start-page: 409 year: 2000 ident: 671_CR20 publication-title: J Am Acad Dermatol doi: 10.1067/mjd.2000.105158 contributor: fullname: A Czelusta – volume: 31 start-page: 57 year: 2003 ident: 671_CR8 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/oxfordjournals.jncimonographs.a003484 contributor: fullname: ML Gillison – volume: 23 start-page: 579 issue: 3 year: 1996 ident: 671_CR2 publication-title: Obstet Gynecol Clin North Am contributor: fullname: H Pfister – volume: 5 start-page: e15256 issue: 12 year: 2010 ident: 671_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0015256 contributor: fullname: L Gao – volume: 27 start-page: 94 issue: 4 year: 2002 ident: 671_CR22 publication-title: Bioquímica contributor: fullname: RP Villanueva – volume: 263 start-page: 2911 year: 1990 ident: 671_CR14 publication-title: JAMA doi: 10.1001/jama.1990.03440210061033 contributor: fullname: JM Palefsky – volume: 93 start-page: 1325 issue: 17 year: 2001 ident: 671_CR25 publication-title: JNCI doi: 10.1093/jnci/93.17.1325 contributor: fullname: J Berumen – volume: 31 start-page: 3 year: 2003 ident: 671_CR1 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/oxfordjournals.jncimonographs.a003479 contributor: fullname: FX Bosch – volume: 19 start-page: 266 year: 2001 ident: 671_CR5 publication-title: Cancer Invest doi: 10.1081/CNV-100102554 contributor: fullname: DM Aboulafia – ident: 671_CR23 doi: 10.1128/jvi.71.3.2463-2472.1997 – volume: 13 start-page: 263 year: 2004 ident: 671_CR3 publication-title: Surg Oncol Clin N Am doi: 10.1016/j.soc.2003.12.005 contributor: fullname: ML Welton – volume: 136 start-page: 54 year: 1992 ident: 671_CR21 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116420 contributor: fullname: CS Rabkin – volume: 344 start-page: 1125 year: 2001 ident: 671_CR6 publication-title: N Engl J Med doi: 10.1056/NEJM200104123441503 contributor: fullname: J Mork – volume: 13 start-page: 487 year: 2012 ident: 671_CR18 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(12)70080-3 contributor: fullname: D Machalek – volume: 54 start-page: 185 year: 2012 ident: 671_CR24 publication-title: J Clin Virol doi: 10.1016/j.jcv.2012.02.014 contributor: fullname: MG Donà – volume: 11 start-page: 178 year: 1996 ident: 671_CR15 publication-title: J Acquir Immunodefic Syndr Hum Retrovirol doi: 10.1097/00042560-199602010-00009 contributor: fullname: RJ Biggar – volume: 12 start-page: 1177 year: 1998 ident: 671_CR16 publication-title: AIDS doi: 10.1097/00002030-199810000-00010 contributor: fullname: CW Critchlow – volume: 4 start-page: 52 issue: 1 year: 2009 ident: 671_CR12 publication-title: Curr Opin HIV AIDS doi: 10.1097/COH.0b013e32831a7246 contributor: fullname: J Palefsky – volume: 22 start-page: 109 year: 2009 ident: 671_CR9 publication-title: Curr Opin Infect Dis doi: 10.1097/QCO.0b013e3283229fc8 contributor: fullname: A Kreutera – volume: 205 start-page: 189 year: 2000 ident: 671_CR4 publication-title: Scand J Urol Nephrol Suppl doi: 10.1080/00365590050509913 contributor: fullname: J Dillner – volume: 92 start-page: 1500 year: 2000 ident: 671_CR11 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.18.1500 contributor: fullname: M Frisch – volume: 197 start-page: 1676 year: 2008 ident: 671_CR19 publication-title: J Infect Dis doi: 10.1086/588145 contributor: fullname: A Nyitray – volume: 9 start-page: 1255 year: 1995 ident: 671_CR26 publication-title: AIDS doi: 10.1097/00002030-199511000-00007 contributor: fullname: CW Critchlow |
SSID | ssj0017829 |
Score | 2.3237066 |
Snippet | Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its... Background Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in... Doc number: 671 Abstract Background: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+)... BACKGROUNDAnal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in... BACKGROUND: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in... |
SourceID | pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 671 |
SubjectTerms | Acquired immune deficiency syndrome Adult AIDS Anal Canal - virology Analysis Antiretroviral Therapy, Highly Active Antiviral agents Anus Neoplasms - virology Cancer Carcinoma in Situ - virology Carcinoma, Squamous Cell - virology Cervical cancer Coinfection DNA, Viral - analysis Drug therapy Health aspects HIV HIV (Viruses) HIV Infections - drug therapy HIV Infections - epidemiology HIV Seropositivity Homosexuality, Male Human immunodeficiency virus Human papillomavirus Humans Incidence Male Medical centers Mexico Middle Aged Molecular Epidemiology Oncology, Experimental Papillomaviridae - genetics Papillomaviridae - isolation & purification Papillomavirus Infections - epidemiology Papillomavirus Infections - virology Prevalence Prevalence studies (Epidemiology) Prevention |
SummonAdditionalLinks | – databaseName: PubMed Central dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXRHkGCjIICQkp3c3DdnrgUFVUBWkBAUW9WY4fbKRsEm12W_gb_GJmss6qruDCZbWbGSfejMfzTeYRQl6J0uSmyF3sskTHubNJXBQujy1LFHxxTFusd5595Gfn-YcLdrFD2FgLMyTt67I6bOrFYVPNh9zKbqEnY57Y5PPsJE8FIuHJLtkF8zu66D50ACbvyIcvk4JPetiABaYE5TFszOAvYftfgAnYie9GkXsd2KabO_Q1ExWmT16zR6d3yR0PJOnxZsL7ZMc298itmQ-V3ye_Zz5VkA6v4aOd6qq6bhfqslquezomYTU9VUvgAR-9_kW7JXb_hgsCnQI0pAqvoYfP1vkzVVhS0hqLvSewcJMOZ4w36V-Xli5sQ6_mLZ0r-NHbnxSf9eLRB-T89N23k7PYv4AhLgEVrWLHbaIRkymumUEwlFrwl-xRyUTGuXCZM4XIS6WzAo7qNHWq5BhcTFyqCp09JHtN29jHhLqpFdoZJxJlc2umqjROaTPVWcbKgpmIvA1EIbtNsw2J7a9DCmii3EhVglQlSlXmEXkzim47dPBvCv435pcoXIn9LxpMsPmh1n0v33_6Lo8ZBi4ZOKX_Yvr6JWB67ZlcC5PTyhc1wJ_GvloB50HACVqsQ_K40KTfRXqJWJlzmLuIyIstGUdiZlxj2zXyCJEJgG1FRB5t1uX2BozrPCIiWLHBzQ0poHJDj3GvYk_-e-RTcjtFpUvSOOEHZG-1XNtngN9W5fNBX_8AjvZKyQ priority: 500 providerName: National Library of Medicine – databaseName: ProQuest Databases dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1rb9Mw0IJOQnxBvCkbyCAkJCRrdR62-wGhgTYNpA40GNo3y_GDVuqSrmkH_A1-MXepW-YJ-BIlvkvi5M7nO9_DhLyQlSucKgILObesCJ4zpULBfMkNnITSesx3Hh2Jw5Piw2l5Ghfc2hhWuZaJnaB2jcU18l3UG4RQcijfzM4Z7hqF3tW4hcZ1spXxXKke2Xq7f_TpeONHgPlvGH2ZXIndFqSxxPiggoGUBuPpSpr7NJmdrsroS5NUGkB5aUY6uE1uRVWS7q1of4dc8_VdcmMUneX3yK9RDBak3UZ8dGZmk-m0OTMXk_mypeswrLqlZg44YKVPf9LZHOt_wwsBTkE5pAbfYbtjE-KTJphU0jiP1ScwdZN2T2SrALALT898Tb-PGzo2cNH6HxRXe7H1Pjk52P_y7pDFLRhYBXrRggXhuUWtzAhbOlSHMg8Wkx9WpcyFkCEPTsmiMjZX0GqzLJhKoHuRh8womz8gvbqp_SNCw8BLG1yQ3PjCu4GpXDDWDWyel5UqXZ-8TkihZ6tyGxoLYKcQ4Au9IqUGUmokpS765NWadJtbOwtHib8hP0fiaqyAUWOIzTezbFv9_uNXvVei67IEs_RfSJ-PE6SXESk00DlrYloDfDRW1kowdxJMGMc2Ba8ZTUc50uo_XN8nzzZgvBNj42rfLBFHylyC4qb65OGKLzc_AAxGjjUn-0QmHJv83BRST8ZdlfEik2huPv5_t7bJzQyHE88YFzukt5gv_RNQ0xbV0zgWfwMkp0Nl priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1ra9RAcKkVxC9S37FVVhEEIXrJbnbTD0WKWKpwCupJvy2bffQOrsmZ3NX2b_iLncnj7JYT_BKSzGQ32dnZmck8lpCXsrDc5tzHniUm5t4lcZ57Hrss0XDiM-Mw33n8WRxP-KeT7GSLDNtb9QPYbDTtcD-pST1_c_Hz8h0w_EHL8Ll428AaKzHqh8ew9oJJdIPcTEEwYoTXmP91KoAw3G-TjQAnZYz3Ts6NTVzLf58HYuv64n1FeoWRlVdE1dEOudPrmPSwmxR3yZYr75Fb496Lfp_8HvdRhLTdoY8u9GI2n1dn-nxWrxo6xGeVDdU14ID5Pr-kixoLg0OHAKegNVKNfZj2WPm-pRlmm1TWYVkKzOmkbYtxFxl27uiZK-mvaUWnGi4ad0HxNzDefUAmRx--vz-O-70Z4gIUpmXshUsMqmtamMyinpQ6MKXcfpFJJoT0zNtc8kIblsNdk6ZeFwL9jolPdW7YQ7JdVqV7TKgfOWm89TLRjjs70oX12tiRYSwr8sxG5CAghVp0dTgUVsYOIcCkqiOlAlIqJKXiEXk9kG79aGv65GIT8gskrsLSGCXG3pzqVdOoj19-qMMMfZoZ2Kv_Qvr2NUB61SP5Cl7O6D7fAT4aS24FmHsBJjC4CcHDRFMDfyhUo4WAd5cReb4G45MYNFe6aoU4UjIJGl0ekUfdvFwPAFiSCRajjIgMZmwwuCGknE3b8uM8lWiHPvmfkdolt1NkqiSNE7FHtpf1yj0FLW5ZPGt58w8wbEjA priority: 102 providerName: Scholars Portal |
Title | Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25510243 https://www.proquest.com/docview/1638668797 https://search.proquest.com/docview/1677375128 http://dx.doi.org/10.1186/s12879-014-0671-4 https://pubmed.ncbi.nlm.nih.gov/PMC4272559 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYJiFeEONrhVEZhISEFFHHju098LBNmwZSByoMVbxYjmPTSl1SNe2Af4O_mLs07eZqPPFiJblf7CTnjzvfRwh5rfJCFFqEJHDmEhE8S7QOIvEZs3AQMucx3rl_Ls8uxMdhNrzOs71hwWdavqthBlXo0yMSmFlB4dkiO6AzcNS0Bkff1yYDWOoOmlAiwKSci9aEeWsVG9Htk2hR2pyab6xNsd_kjYXo9AG530qQ9HDJ8l1yx5cPyd1-ayN_RP70Wx9B2vx_j07tdDyZVJf2ajxb1HTlfVXW1M4AA8r55DedzjDtNzQIdAoyIbXYhmvKKrQ1jTGWpCo8Jp3AiE3a1Jgs_b6uPL30Jf05qujIwkntf1Hc5MWrj8nF6cnX47Ok_fNCkoM4NE-C9MyhMGalywqUglIPipI_yDPFpVSBh0IrkVvHNVx1aRpsLtGqyEJqteNPyHZZlX6P0NDzyoUiKGa98EXP5kWwrug5zrNcZ0WHvI9YYabLLBsG817HFBiCZslKA6w0yEojOuTtinXrWxvFRsvbwK-QuQYTX5ToWfPDLurafPj0zRxmaLHMoGf9C_RlEIHetKBQwcM520YzwEtjQq0IuR8hYfi6mLzqaKadPmqDQrKU8OyqQ16uyXgnusSVvlogRimuQF7THfJ02S_XHwD0RIapJjtERT02-rgxpRyPmuTiIlWoZT77T7Y8J_dSHG8sTZjcJ9vz2cK_APFtnnfJlhoqKPUx65Kdo5Pzz4NusxUCZV_objOsu82-219H0Uv1 |
link.rule.ids | 108,230,314,727,780,784,864,885,2221,12056,12223,21388,24318,24937,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,53791,53793,75811,75812 |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rbxMxDI-gk4AviOcoDAgICQkpWu-VpB8QGmjTBmtBY0P7FuXyoJW6u9JrB_wb_MXY17QsE_Clas--R8-OY8f2L4S8EKXNrcw981liWO5dwqT0OXNFouGLL4zDfufBkO-f5O9Pi9Ow4NaEssqVTWwNta0NrpFvo9_AuRR98Wb6jeGuUZhdDVtoXCUbiJxedMjG293hp6N1HgHmv37IZSaSbzdgjQXWB-UMrDQET5fa3CfR7HTZRl-YpOICygsz0t4tcjO4knRnKfvb5Iqr7pBrg5Asv0t-DUKxIG034qNTPR1PJvWZPh_PFg1dlWFVDdUz4IEoffKTTmeI_w03BDoF55BqvIdpP2sfrjTGppLaOkSfwNZN2l6RLQvAzh09cxX9PqrpSMOPxv2guNqLR--Rk73d43f7LGzBwErwi-bMc5cY9Mo0N4VFdyh1EDG5flmIjHPhM2-lyEttMglHTZp6XXJMLyY-1dJk90mnqiv3gFDfc8J460WiXe5sT5fWa2N7JsuKUha2S15HolDTJdyGQgDsmAJ6oZaiVCBKhaJUeZe8WolufWob4Uj-N-bnKFyFCBgVlth81YumUQcfv6idAlOXBYSl_2L6fBQxvQxMvoaHMzq0NcCfRmStiHMr4oRxbGLyStFUsCON-qP1XfJsTcYzsTaucvUCeYTIBDhusks2l3q5fgEQMCaIOdklItLY6OXGlGo8alHG81RguPnw_4_1lFzfPx4cqsOD4YdH5EaKQytJWcK3SGc-W7jH4LLNyydhXP4GZZxGTQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtNAcAVFqrgg3pgWWBASEpJpbK933QOH8ohaIAUViqpeVut9kKiJHcVJgd_gi5mxN1G2Kiculu0Zr-2dx854HibkuSgNMwVzscsSHTNnk7goHIttnijYcbm2WO88OOT7x-zDSX7iK-uwFqac6GUW0qLxMYrm1Xop-rjV37Cjz3amxnViX_CdBjStwNwfFoMGBsfoKrkGxnArrUdvTlehBVgSd9uSI8BJs4z5UOelQ1yogh8Hi9dFFb62hoX5lWsLVv8mueEtTbrXscYtcsVWt8nmwMfS75A_A59LSNv_9NGpmo7G43qizkezRUOX81M1VM0AB5z48W86nWF7cLghwCnYjlThPXS7rZ0faYQ1J7Wx2JwCKztpO2Lc5YedWzqxFf05rOlQwUFjf1H8GIxn75Lj_vtvb_dj_4eGuASzaR47bhONRpviOjdoLaUWHCq7W-Yi41y4zJlCsFLprICzOk2dKjlGHxOXqkJn98hGVVf2AaGuZ4V2xolEWWZNT5XGKW16OsvysshNRF4HpJDTrhuHxP7YIQT4Q3aklEBKiaSULCIvl6RbXdo6QAW_DPkZEldig4wKM3B-qEXTyIPP3-VejpHNHLzWfyF9PQqQXngkVyPPKl_1AC-NjbcCzO0AE8Rch-Alo0mvZhqJxjTn8OwiIk9XYLwSU-cqCzIEOEJkAuy6IiL3O75cTQD4kwm2pIyICDg2mNwQUo2GbRNylgr0Rh_-J1mekM0v7_ry08Hhxy1yPUXRS9I44dtkYz5b2Edg8c3Lx60E_wWMMliP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+human+papillomavirus+infections+are+highly+prevalent+in+the+anal+canal+of+human+immunodeficiency+virus-positive+men+who+have+sex+with+men&rft.jtitle=BMC+infectious+diseases&rft.au=M%C3%B1ndez-Mart%C3%ADnez%2C+Roc%C3%ADo&rft.au=Rivera-Mart%C3%ADnez%2C+Norma+E&rft.au=Crabtree-Ram%C3%ADrez%2C+Brenda&rft.au=Sierra-Madero%2C+Juan+G&rft.date=2014-12-16&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=14&rft_id=info:doi/10.1186%2Fs12879-014-0671-4&rft.externalDBID=IOV&rft.externalDocID=A539575249 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |